<DOC>
	<DOCNO>NCT01733134</DOCNO>
	<brief_summary>Patients hospitalize acute heart failure already receive standard therapy randomize receive either tolvaptan placebo , base level copeptin measure bloodstream . Patients high copeptin level able participate trial , patient low level exclude . Patients admitted observation unit acute heart failure already receive standard therapy randomize receive either tolvaptan placebo without consideration copeptin level . The hypothesis patient receive tolvaptan well improvement shortness breath receive placebo , within 9 hour drug administration .</brief_summary>
	<brief_title>Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation Treatment ( ACTIVATE )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<criteria>1 . Older equal 18 year age , diagnosis plan treatment Acute Heart Failure 2 . Dyspnea rest minimal exertion per patient 3 . Evidence extracellular volume expansion least one following : JVD , Rales , Ascites , Edema positive Chest Xray define cardiomegaly , pulmonary vascular congestion , Kerley Blines , pulmonary edema and/or pleural effusion . 4 . Elevated BNP level &gt; 200 pg/ml , NTproBNP &gt; 1000pg/mL 5 . Able administer study drug within 8 hour triage time Inpatient Hospitalized Inclusion Only : Copeptin level &gt; 27 pmol/L 1 . Unable provide inform consent 2 . Unable 30 day telephone follow 3 . Not expect survive past 6 month 4 . On Renal replacement therapy creatinine &gt; 3.5 5 . History allergy intolerance Tolvaptan 6 . Suspected Pregnancy 7 . Cardiogenic Shock 8 . Participation interventional trial prior 30 day . 9 . Receiving plan receive IV Inotropic therapy 10 . ACS past 30 day 11 . Treatment IV infusion vasoactive drug hour prior enrollment 12 . Temperature &gt; 100.5 13 . Heart Failure due atrial fibrillation Rapid Ventricular Response 14 . SBP &lt; 90 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>acute heart failure</keyword>
	<keyword>emergency department</keyword>
	<keyword>copeptin</keyword>
	<keyword>adh antagonist</keyword>
</DOC>